A professor says that Indonesia needs to follow up on India's success in facilitating affordable prices for medicines and medical devices for public.

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment ... chalazion/hordeolum (stye) and punctate keratitis.

The new warnings need to be printed at the start of information leaflets given to both patients ... speak to your doctor who can discuss the risks and benefits of the medication for you, and, if ...

"Patients must be informed about the potential risks, benefits, and outcomes of the procedure, as well as alternatives (including the option of no treatment ... to share this very intimate information ...

Correspondence to Dr Suet Yi Leung, Department of Pathology, School of Clinical Medicine, The University of Hong Kong ... offering new mechanistic information on RHO-ROCK pathway inhibition that ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

As a pharmacist-health services researcher, Dr. Antoinette Coe studies how to improve medication use and safety. Some of her ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...